XML 62 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes (Tables)
12 Months Ended
Jul. 31, 2024
Income Tax Disclosure [Abstract]  
Income before provision for income taxes
Loss before benefit from income taxes consists of the following:
 Fiscal Years Ended July 31,
 202420232022
U.S.$(65,374,000)(21,327,000)(31,772,000)
Foreign(34,906,000)(9,520,000)(5,303,000)
 $(100,280,000)(30,847,000)(37,075,000)
Provision for income taxes
The benefit from income taxes included in the accompanying Consolidated Statements of Operations consists of the following:
 Fiscal Years Ended July 31,
 202420232022
Federal – current$377,000 (258,000)287,000 
Federal – deferred(2,345,000)(4,623,000)(4,888,000)
State and local – current1,181,000 1,412,000 348,000 
State and local – deferred(834,000)(815,000)(442,000)
Foreign – current1,137,000 958,000 1,197,000 
Foreign – deferred189,000 (622,000)(525,000)
Benefit from income taxes$(295,000)(3,948,000)(4,023,000)
Provision for income taxes differed from amounts computed by applying the U.S. Federal income tax rate
The benefit from income taxes differed from the amounts computed by applying the U.S. Federal income tax rate as a result of the following:
 Fiscal Years Ended July 31,
 202420232022
 AmountRateAmountRateAmountRate
Computed "expected" tax benefit$(21,059,000)21.0 %(6,478,000)21.0 %(7,786,000)21.0 %
Increase (reduction) in income taxes resulting from:      
State and local income taxes, net of federal benefit(127,000)0.1 440,000 (1.4)227,000 (0.6)
Stock-based compensation1,891,000 (1.9)692,000 (2.2)1,049,000 (2.8)
Research and experimentation credits(1,251,000)1.2 (2,576,000)8.4 (1,484,000)4.0 
Foreign-derived intangible income deduction43,000 — (517,000)1.7 — — 
Revaluation of convertible preferred stock option liability— — — — (211,000)0.6 
Revaluation of warrants(897,000)0.9 — — — — 
Nondeductible executive compensation— — 1,484,000 (4.8)2,801,000 (7.6)
PST Divestiture1,384,000 (1.4)— — — — 
Change in valuation allowance10,177,000 (10.0)2,834,000 (9.2)2,009,000 (5.4)
Remeasurement of deferred taxes— — — — (396,000)1.1 
Foreign income taxes(389,000)0.4 (269,000)0.9 (478,000)1.3 
Goodwill impairment9,549,000 (9.5)— — — — 
Other, net384,000 (0.5)442,000 (1.6)246,000 (0.7)
Benefit from income taxes$(295,000)0.3 %(3,948,000)12.8 %(4,023,000)10.9 %
Tax effects of temporary differences
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at July 31, 2024 and 2023 are presented below:
 20242023
Deferred tax assets:  
Inventory and warranty reserves$4,685,000 6,147,000 
Compensation and commissions3,401,000 3,221,000 
Federal, state and foreign research and experimentation credits17,559,000 19,308,000 
Capitalized U.S. research and experimental expenditures12,177,000 8,784,000 
Stock-based compensation2,409,000 4,774,000 
Foreign scientific research and experimental development expenditures1,720,000 2,118,000 
Federal, state and foreign net operating losses18,289,000 13,011,000 
Federal and state capital losses14,473,000 15,582,000 
Lease liabilities8,999,000 11,986,000 
Deferred revenue, non-current4,664,000 4,463,000 
163(j) Interest Expense Limitation3,423,000 549,000 
Other1,278,000 1,868,000 
Less: valuation allowance(44,888,000)(34,478,000)
Total deferred tax assets48,189,000 57,333,000 
 Deferred tax liabilities:  
Plant and equipment(4,781,000)(4,883,000)
Lease right-of-use assets(7,116,000)(10,510,000)
Intangibles(42,563,000)(50,843,000)
Total deferred tax liabilities(54,460,000)(66,236,000)
Net deferred tax liabilities$(6,271,000)(8,903,000)
Summary of unrecognized tax benefits The following table summarizes the activity related to our unrecognized tax benefits for fiscal years 2024, 2023 and 2022 (excluding interest):
 202420232022
Balance at beginning of period$8,956,000 9,675,000 9,009,000 
Increase related to current period181,000 681,000 598,000 
Increase related to prior periods130,000 51,000 153,000 
Expiration of statute of limitations(622,000)(1,406,000)(83,000)
Decrease related to prior periods(264,000)(45,000)(2,000)
Balance at end of period$8,381,000 8,956,000 9,675,000